×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| INVESCO India Gold Exchange Tr | NA | NA | NA | NA | 0 | |
| MOTILAL OSWAL MOST SHARES NASD | NA | NA | NA | NA | 0 | |
| Emcure Pharmaceuticals Limited | 12833.57 | 1176.22 | 12606.04 | 6.21 | 24,337 | 32.3 |
| Aadhar Housing Finance Limited | 8992.6 | 2664.7 | 8971.3 | 6.03 | 22168 | 23.4 |
| Brookfield India Real Estate T | NA | NA | NA | NA | 21824 | 85.3 |
Emcure Pharmaceuticals Limited has established itself in the None sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
Failed to load quarterly data. Please try again later.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 13% |
| 3 Years: | 9% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | -11% |
| TTM: | 95% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 36% |
| 3 Years: | 1% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|